PRAZEPAM Drug Patent Profile
✉ Email this page to a colleague
When do Prazepam patents expire, and what generic alternatives are available?
Prazepam is a drug marketed by Usl Pharma and is included in two NDAs.
The generic ingredient in PRAZEPAM is prazepam. There are four drug master file entries for this compound. Additional details are available on the prazepam profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRAZEPAM?
- What are the global sales for PRAZEPAM?
- What is Average Wholesale Price for PRAZEPAM?
Summary for PRAZEPAM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 35 |
| Patent Applications: | 4,008 |
| DailyMed Link: | PRAZEPAM at DailyMed |
Medical Subject Heading (MeSH) Categories for PRAZEPAM
Anatomical Therapeutic Chemical (ATC) Classes for PRAZEPAM
US Patents and Regulatory Information for PRAZEPAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Usl Pharma | PRAZEPAM | prazepam | CAPSULE;ORAL | 070427-001 | Nov 6, 1987 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Usl Pharma | PRAZEPAM | prazepam | CAPSULE;ORAL | 070428-001 | Nov 6, 1987 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
